Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 2.985
+0.030 (1.02%)
Mar 23, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 374.9 million as of March 23, 2026. Its market cap has increased by 23.84% in one year.
Market Cap
374.90M
Enterprise Value
326.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.99
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 374.90M, a decrease of -33.33%. That is a compound annual growth rate of -5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 374.90M | -8.09% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FluoGuide | 712.83M |
| Infant Bacterial Therapeutics AB | 649.32M |
| Oncopeptides AB | 591.35M |
| Corline Biomedical AB | 405.97M |
| Intervacc AB | 333.66M |
| Bio-Works Technologies AB | 314.18M |
| Mendus AB | 257.97M |
| Elicera Therapeutics AB | 256.27M |